Pediatric and Adult Cerebral Arteriovenous Malformation Neurofunctional Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-04-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cerebral Arteriovenous malformations (AVMs) are abnormal tangles which are usually believed congenital. AVM can cause different symptoms depending on where it is located, but the most common symptoms are intracranial hemorrhage and seizure. Outcomes of AVM patients can be very different due to factors like the location of lesion, age, sex etc. Generally, more early the intervention was taken, the risk of adverse events would be lower. But the selection of surgical timing for pediatric AVM patients is hard to judge, due to children's cerebral vessels angioarchitecture can be still developing with their age. Some previous studies indicated that there is no difference in intervention outcomes between pediatric and adult AVM patients, so pediatric patients should undergo more aggressive intervention. DOPA study aims to compare the clinical intervention outcomes of both pediatric and adult patients with eloquent region cerebral arteriovenous malformations, helping to determine the treatment strategy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study

NCT02946866

Cerebral Cavernous Malformation Intracerebral Hemorrhage

UNKNOWN

Brain White Matter Injury in Late Preterm Infants

NCT04508517

White Matter Injury

UNKNOWN

Modifiers of Disease Severity in Cerebral Cavernous Malformations

NCT01764529

Cavernous Angioma, Familial Cerebral Cavernous Malformations Cerebral Cavernous Hemangioma

ACTIVE_NOT_RECRUITING

Childhood Outcomes of Preterm Brain Abnormalities

NCT03410810

Premature Birth Neurodevelopmental Disorders Brain Development Abnormality +1 more

RECRUITING

Neurophysiology and Anatomy of Severe Intraventricular Hemorrhage (IVH)

NCT00817310

Intracranial Hemorrhages Prematurity

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Follow-up: In the investigators' neurosurgical center, follow-up was conducted for all participants at the first 3-6 months and annually after discharge by clinical visit and telephone interview.

Study overview: DOPA will aim on outcomes of both pediatric and adult AVMs patients who underwent intervention in investigators' institution. Intervention strategies contains microsurgical resection, embolization, embolization + radiosurgery, and single-stage hybrid surgery (embolization + resection). Outcomes will be measured by a neurologist using Modified Rankin Scale (mRs). Participants' mRs\<2 will be considered as a good outcome and investigators will keep follow-up with every patient for at least 3 years.

Sample size: About 300 patients will be enrolled in this study, and adults and children will account for half. All kinds of intervention will be included. The distribution of different strategies is excepted as: 30% resection, 20% embolization, 30% embolization + radiosurgery and 20% hybrid surgery.

Study endpoints: The patients' mRs, occlusion rate and complication will be evaluated at 2 weeks, discharge from hospital, 1 year and 3 years after the first-time intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Arteriovenous Malformation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pediatric AVM

1. AVM patients' age under 18-years-old who underwent intervention in investigators' institution.
2. Patients' lesions were located in eloquent and confirmed by image.

No interventions assigned to this group

Adult AVM

1. AVM patients' age over 18-years-old who underwent intervention in investigators' institution.
2. Patients' lesions were located in eloquent and confirmed by image.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The diagnosis of AVM was confirmed with digital subtraction angiography (DSA) and/or magnetic resonance imaging(MRI).
* Patients had underwent interventions in our institution.
* AVMs were located in eloquent area.